Literature DB >> 21632050

Baseline cerebral oximetry values in elderly patients with hip fractures: a prospective observational study.

Georgios Papadopoulos1, Menelaos Karanikolas, Antonia Liarmakopoulou, Alexandros Berris.   

Abstract

AIM: This study was conducted to evaluate baseline cerebral tissue regional oxygen saturation (rSO(2)) values and identify risk factors related to severe rSO(2) reductions in elderly patients with hip fractures. PATIENTS AND METHODS: This was a prospective observational single-centre study on patients undergoing scheduled or urgent operation for isolated hip fracture. The study was approved by the Institution Ethics Committee, and all patients signed informed consent before entering the study. Data were collected on factors potentially related to baseline cerebral rSO(2). Data were analysed with Student's t-test, Pearson's correlation or multiple regression analysis as appropriate.
RESULTS: Sixty-nine patients, aged (mean±standard deviation (SD)) 74±13 years participated. Left baseline rSO(2) was 60.09±10.20 and right baseline rSO(2) was 58.64±9.92. Baseline rSO(2)<45 was observed in 10.1% of patients on the left and 8.7% on the right side. Correlation between left- and right-side baseline cerebral rSO(2) was highly significant (r=0.852, p<0.001). Baseline cerebral rSO(2) had a positive, highly significant correlation with preoperative haematocrit (r=0.50, p<0.001) and arterial haemoglobin oxygen saturation (SpO(2)) (r=0.587, p<0.001), but correlation was negative with the American Society of Anesthesiologists (ASA) physical status (r=-0.42, p<0.001) and age (r=-0.39, p=0.001). Linear regression showed that preoperative haematocrit accounts for 23% (R(2)=0.23) of baseline rSO(2) variability, whereas preoperative haematocrit and SpO(2) combined account for 43.7% of rSO(2) variability (R(2)=0.437). Combined preoperative haematocrit+SpO(2)+age accounted for 51.3% (R(2)=0.513) of observed rSO(2) variability.
CONCLUSION: Low baseline cerebral rSO(2) values are common in elderly hip fracture patients, despite normal haemodynamic and arterial saturation values. Preoperative haematocrit, SpO(2) and age explain a significant portion of cerebral rSO(2) variability. More studies are needed to validate our findings and assess the potential benefit of interventions aimed at improving cerebral rSO(2) in elderly hip fracture patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632050     DOI: 10.1016/j.injury.2011.04.015

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Effect of anesthetic methods on cerebral oxygen saturation in elderly surgical patients: prospective, randomized, observational study.

Authors:  Aerina Lee; Sung-Hoon Kim; Jeong-Yeon Hong; Jai-Hyun Hwang
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

2.  The relationship between carotid artery colour Doppler finding and cerebral oximetry.

Authors:  Mohammad Sobhan Ardakani; Manouchehr Heidari; Reza Nafisi Moghaddam; Mahdi Haddadzadeh; Hossein Moshtaghion; Ali Akbar Rahimianfar
Journal:  Adv Biomed Res       Date:  2015-05-11

3.  Monitoring of brain oxygen saturation (INVOS) in a protocol to direct blood transfusions during cardiac surgery: a prospective randomized clinical trial.

Authors:  George Vretzakis; Stavroula Georgopoulou; Konstantinos Stamoulis; Vassilios Tassoudis; Dimitrios Mikroulis; Athanasios Giannoukas; Nikolaos Tsilimingas; Menelaos Karanikolas
Journal:  J Cardiothorac Surg       Date:  2013-06-07       Impact factor: 1.637

4.  The effect of tourniquet deflation on hemodynamics and regional cerebral oxygen saturation in aged patients undergoing total knee replacement surgery.

Authors:  Inkyung Song; Dong Yeon Kim; Youn Jin Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16

5.  Low preoperative regional cerebral oxygen saturation in hemodialysis patients.

Authors:  Shino Matsukawa; Miho Hamada; Toshiyuki Mizota
Journal:  JA Clin Rep       Date:  2017-04-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.